Doctor of Pharmacology, Virginia Medical College, postdoctoral fellow, Harvard Medical College, graduated from Peking University and School of Public Health, Fudan University.
He once worked as an assistant researcher at the Institute of Biological Products Drug Identification of the Ministry of Health of China, a senior researcher at the School of Medicine of Stanford University in the United States, and the director of technology and development in the Asia-Pacific region of Bayer Pharmaceutical Company.
Founded in Shanghai Jida Gene Technology Co., Ltd., managing director; Developed internationally advanced gene diagnosis technologies and products, including 8 Shanghai Magnolia Talent Awards and 4 molecular biology technology patents from the Shanghai Municipal Government Development Fund.
Wuxi Daqiao Biomedical Technology Co., Ltd., founded by Dr. Cao Bo, is the leader of the entrepreneurial plan of returned overseas students in Wuxi (that is, Wuxi "530" plan), and is assigned to Class A, which is one of the main highlights of high-tech incubators in provinces and cities. Its project "chemical analysis of immune system of hand-held electronic sensor" is characterized by combining the fastest test reagent and the design of electrochemical sensor electrode specimen, and a plug-and-play portable memory card interface can be used to perform the test on a notebook computer (NB) or personal digital assistant (PDA), which is simple and only takes three minutes to complete the test. This product is simple, convenient, fast, time-saving and trouble-saving, and the antibody specificity recognized by biotechnology industry leads to the high stability of the product, which is of great promotion value.